PTPRC and acute respiratory distress syndrome: The group with the early application of the CC16 Ab, showed a significantly increased percentage of CD16+Ly6G+CD45+ viable cells in the BAL, compared to the sham, as well as the control and IgG ALI groups, at 6 hours post-CLP (p < 0.05, Figure 5C).